Results 31 to 40 of about 740,964 (300)

The design of Indonesian SARS‐CoV‐2 primers based on phylogenomic analysis of the SARS‐CoV‐2 clades

open access: yesIndonesian Journal of Biotechnology, 2022
Molecular detection needs to be augmented for COVID‐19 detection in Indonesia using the PCR method with primer‐based gene analysis. This is necessary because the RNA of the SARS‐CoV‐2 virus, the causative infectious agent of the pandemic, has been ...
Tsania Taskia Nabila   +3 more
doaj   +1 more source

ORF8/ORF8a: a difference between SARS-CoV-2 and SARS-CoV [PDF]

open access: yesEuropean Respiratory Journal, 2021
ORF8 as an accessory protein of SARS-CoV-2 https://bit.ly ...
openaire   +2 more sources

Human monoclonal antibody combination against SARS coronavirus : synergy and coverage of escape mutants [PDF]

open access: yes, 2006
Background: Experimental animal data show that protection against severe acute respiratory syndrome coronavirus (SARS-CoV) infection with human monoclonal antibodies (mAbs) is feasible.
Peiris, Joseph S. M.   +73 more
core   +1 more source

Susceptibility of lung cancer patients to COVID‐19: A review of the pandemic data from multiple nationalities

open access: yesThoracic Cancer, 2021
Several studies have highlighted that cancer patients tend to be more susceptible to develop severe infection and to die from COVID‐19. Certain medical conditions such as immunosuppression, presence of comorbidities, and underlying pulmonary damage are ...
Ana Emília Goulart Lemos   +3 more
doaj   +1 more source

Seroprevalence of IgG antibodies to SARS-coronavirus in asymptomatic or subclinical population groups. [PDF]

open access: yes, 2006
We systematically reviewed the current understanding of human population immunity against SARS-CoV in different groups, settings and geography. Our meta-analysis, which included all identified studies except those on wild animal handlers, yielded an ...
Donnelly, CA   +12 more
core   +1 more source

Immune Responses to SARS-CoV, MERS-CoV and SARS-CoV-2 [PDF]

open access: yes, 2020
The world has given an outbreak alarm in the last two decades, with different members of the coronavirus family infecting people at different times. The spread of the SARS-CoV-2 virus, which last appeared in December 2019 in China and spread rapidly to all over the world, has led the scientific world to studies on these viruses.
İnandıklıoğlu, Nihal, Akkoc, Tunc
openaire   +3 more sources

Electrostatic features for nucleocapsid proteins of SARS-CoV and SARS-CoV-2

open access: yesMathematical Biosciences and Engineering, 2021
<abstract> <p>COVID-19 is increasingly affecting human health and global economy. Understanding the fundamental mechanisms of Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) is highly demanded to develop treatments for COVID-19.
Wenhan Guo   +4 more
openaire   +3 more sources

Reporte N°14: Vigilancia activa de variantes de SARS-CoV-2 en la Provincia de Córdoba. Actualización al 8/2/2021 [PDF]

open access: yes, 2021
Participantes en este reporte: • Nodo de secuenciación de Córdoba del IPAVE-INTA-CIAP: Franco Fernández, Nathalie Marquez y Humberto Debat. • Nodo de secuenciación de EEA Rafaela-INTA-CONICET (Provincia de Santa Fe): Matías Irazoqui, Ariel Amadío ...
Gobierno de la Provincia de Córdoba. Ministerio de Salud. Laboratorio Central   +4 more
core   +1 more source

Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH-and Cysteine Protease-Independent Fc gamma R Pathway [PDF]

open access: yes, 2011
Copyright © 2011, American Society for Microbiology. All Rights Reserved.Public health measures successfully contained outbreaks of the severe acute respiratory syndrome coronavirus (SARS-CoV) infection.
Cheung, Chung y   +40 more
core   +1 more source

Anti-SARS-CoV-2 S-RBD IgG antibody and anti-SARS-CoV-2 NAb levels.

open access: yes, 2023
Anti-SARS-CoV-2 S-RBD IgG antibody and anti-SARS-CoV-2 NAb levels.
Lugyanti Sukrisman (4808703)   +11 more
core   +1 more source

Home - About - Disclaimer - Privacy